Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study
Go back to Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study| (NASDAQ: EDSA) | Delayed: 7.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.64 | 52 Week High | $ | |||
| Open | $7.64 | 52 Week Low | $ | |||
| Day High | $7.64 | P/E | N/A | |||
| Day Low | $7.64 | EPS | $ | |||
| Volume | 1,557 | |||||
